US5962527A
(en)
*
|
1995-03-21 |
1999-10-05 |
The Board Of Trustees Of The University Of Illinois |
Method and composition for treating cancers
|
US5869535A
(en)
*
|
1995-03-21 |
1999-02-09 |
The Board Of Trustees Of The University Of Illinois |
Method and composition for selectively inhibiting melanoma
|
EP0902685A1
(de)
*
|
1997-01-24 |
1999-03-24 |
Marigen S.A. |
Ultramikroemulsionen aus spontan dispergierbaren konzentraten enthaltend antitumoral, antiviral und antiparasitär wirksame ester von pentacyclischen triterpenen
|
US5750578A
(en)
*
|
1997-02-11 |
1998-05-12 |
Regents Of The University Of Minnesota |
Use of betulin and analogs thereof to treat herpesvirus infection
|
EP0988311B9
(de)
*
|
1997-06-04 |
2004-12-15 |
Cornell Research Foundation, Inc. |
Betulinolderivate
|
US6228850B1
(en)
*
|
1997-09-30 |
2001-05-08 |
Dabur Research Foundation |
Antiangiogenic activity of betulinic acid and its derivatives
|
US6670345B1
(en)
*
|
1997-09-30 |
2003-12-30 |
Dabur Research Foundation |
Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid
|
US6048847A
(en)
*
|
1997-09-30 |
2000-04-11 |
Dabur Research Foundation |
Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this
|
AU762404B2
(en)
*
|
1998-03-02 |
2003-06-26 |
Panacos Pharmaceuticals, Inc. |
Acylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
|
US6303589B1
(en)
*
|
1998-12-08 |
2001-10-16 |
Micro Flo Company |
Pentacyclic triterpenes
|
US6369101B1
(en)
|
1999-02-26 |
2002-04-09 |
Regents Of The University Of Minnesota |
Therapeutic method to treat herpes virus infection
|
US6392070B1
(en)
*
|
1999-08-10 |
2002-05-21 |
Regents Of The University Of Minnesota |
Birch bark processing and the isolation of natural products from birch bark
|
DE69917684T2
(de)
*
|
1999-09-09 |
2005-07-21 |
Dabur Research Foundation, Sahibabad |
Betulinsäure-derivate mit antiangiogener wirkung, verfahren zur herstellung solcher derivate und deren verwendung für die behandlung tumorassoziierter angiogenese
|
WO2002091858A1
(en)
*
|
2001-05-11 |
2002-11-21 |
University Of Ottawa |
Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
|
US20040131629A1
(en)
*
|
2002-09-26 |
2004-07-08 |
Panacos Pharmaceuticals, Inc. |
Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
|
US7365221B2
(en)
*
|
2002-09-26 |
2008-04-29 |
Panacos Pharmaceuticals, Inc. |
Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
|
CA2514563A1
(en)
*
|
2003-01-29 |
2004-08-19 |
Panacos Pharmaceuticals, Inc. |
Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
|
US7537765B2
(en)
*
|
2003-01-29 |
2009-05-26 |
Panacos Pharmaceuticals, Inc. |
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
|
US7026305B2
(en)
*
|
2003-04-14 |
2006-04-11 |
Meharry Medical College |
Anti-HIV agents with dual sites of action
|
EP1730163A4
(de)
*
|
2004-03-17 |
2009-12-30 |
Panacos Pharmaceuticals Inc |
Pharmazeutische salze von 3-o-(3,3-dimethylsuccinyl)betulinsäure
|
CN100591688C
(zh)
*
|
2004-03-17 |
2010-02-24 |
帕纳克斯医药公司 |
3-0-(3',3'-二甲基琥珀酰基)桦木酸的药用盐
|
US20060019934A1
(en)
*
|
2004-05-20 |
2006-01-26 |
Saxena Brij B |
Anti-HIV-1 activity of betulinol derivatives
|
MXPA06013698A
(es)
*
|
2004-05-24 |
2007-08-15 |
Panacos Pharmaceuticals Inc |
Inhibicion de replicacion de virus 1 de inmunodeficiencia humana (vih-1) por interrupcion del procesamiento de la proteina de capsida-peptido separador 1 viral.
|
US20060154904A1
(en)
|
2004-09-10 |
2006-07-13 |
Cornell Research Foundation, Inc. |
Betulinol derivatives as anti-HIV agents
|
TW200628161A
(en)
*
|
2004-11-12 |
2006-08-16 |
Panacos Pharmaceuticals Inc |
Novel betulin derivatives, preparation thereof and use thereof
|
RU2007141631A
(ru)
*
|
2005-04-12 |
2009-05-20 |
Панакос Фармасьютикалз, Инк. (Us) |
Полиморфы ди-n-метил-d-глюкамина 3-о-(3',3'-диметилсукцинил)бетулиновой кислоты
|
EP1893629A4
(de)
*
|
2005-06-22 |
2008-12-17 |
Myriad Genetics Inc |
Antivirale verbindungen
|
AU2006333084A1
(en)
*
|
2005-12-16 |
2007-07-12 |
Panacos Pharmaceuticals, Inc. |
Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl) betulinic acid
|
WO2007114978A2
(en)
*
|
2006-02-09 |
2007-10-11 |
Boehringer Ingelheim International Gmbh |
Method for treating hiv infection through co-administration of tipranavir and pa-457
|
US20070232577A1
(en)
*
|
2006-03-23 |
2007-10-04 |
Advanced Life Sciences, Inc. |
Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin
|
US20080039428A1
(en)
*
|
2006-06-29 |
2008-02-14 |
Panacos Pharmaceuticals, Inc. |
Antiretroviral combination therapy
|
US20090105203A1
(en)
*
|
2006-10-16 |
2009-04-23 |
Myriad Genetics, Incorporated |
Compounds for treating viral infections
|
WO2008057420A2
(en)
|
2006-11-03 |
2008-05-15 |
Panacos Pharmaceuticals, Inc. |
Extended triterpene derivatives
|
US20110152229A1
(en)
*
|
2006-11-22 |
2011-06-23 |
Duke University |
Betulinic acid derivatives as anti-hiv agents
|
US9067966B2
(en)
|
2009-07-14 |
2015-06-30 |
Hetero Research Foundation, Hetero Drugs Ltd. |
Lupeol-type triterpene derivatives as antivirals
|
PL2576586T3
(pl)
*
|
2010-06-04 |
2016-01-29 |
Bristol Myers Squibb Co |
C-28 amidy zmodyfikowanych pochodnych kwasu C-3 betulinowego jako inhibitory dojrzewania HIV
|
EA022393B1
(ru)
*
|
2010-06-04 |
2015-12-30 |
Бристол-Майерс Сквибб Компани |
С-3 модифицированные производные бетулиновой кислоты в качестве ингибиторов созревания вич
|
RU2448115C1
(ru)
*
|
2010-12-20 |
2012-04-20 |
Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Новосибирский национальный исследовательский государственный университет" (Новосибирский государственный университет (НГУ) |
Гидрированная бетулоновая кислота и ее амиды как противоопухолевые средства тритерпеновой природы
|
EA022470B1
(ru)
|
2011-01-31 |
2016-01-29 |
Бристол-Маерс Сквибб Компани |
C-17 и c-3 модифицированные тритерпеноиды с ингибиторной активностью созревания вич
|
PL2670764T3
(pl)
|
2011-01-31 |
2016-02-29 |
Bristol Myers Squibb Co |
C-28 aminy zmodyfikowanych C-3 pochodnych kwasu betulinowego jako inhibitory dojrzewania HIV
|
KR20140069167A
(ko)
|
2011-09-21 |
2014-06-09 |
브리스톨-마이어스 스큅 컴퍼니 |
항바이러스 활성을 갖는 신규 베툴린산 유도체
|
US8906889B2
(en)
|
2012-02-15 |
2014-12-09 |
Bristol-Myers Squibb Company |
C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
|
US8889854B2
(en)
|
2012-05-07 |
2014-11-18 |
Bristol-Myers Squibb Company |
C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
|
CN103768078B
(zh)
|
2012-10-22 |
2019-02-05 |
北京大学 |
三萜衍生物及其抗流感用途
|
WO2014105926A1
(en)
|
2012-12-31 |
2014-07-03 |
Hetero Research Foundation |
Novel betulinic acid proline derivatives as hiv inhibitors
|
CA2900124A1
(en)
|
2013-02-06 |
2014-08-14 |
Bristol-Myers Squibb Company |
C-19 modified triterpenoids with hiv maturation inhibitory activity
|
JP6186012B2
(ja)
|
2013-02-25 |
2017-08-23 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
C−3アルキルおよびアルケニル修飾ベツリン酸誘導体
|
HUE051719T2
(hu)
|
2014-04-11 |
2021-03-29 |
Viiv Healthcare Uk No 4 Ltd |
Triterpenoidok HIV érésgátló aktivitással, amelyek a 3-helyzetben egy halogénalkil-szubsztituenst hordozó nem-aromás gyûrûvel helyettesítettek
|
WO2015195776A1
(en)
|
2014-06-19 |
2015-12-23 |
Bristol-Myers Squibb Company |
Betulinic acid derivatives with hiv maturation inhibitory activity
|
US20170129916A1
(en)
|
2014-06-26 |
2017-05-11 |
Hetero Research Foundation |
Novel betulinic proline imidazole derivatives as hiv inhibitors
|
US9969767B2
(en)
|
2014-11-14 |
2018-05-15 |
VIIV Healthcare UK (No.5) Limited |
Oxolupene derivatives
|
CA2967684A1
(en)
|
2014-11-14 |
2016-05-19 |
VIIV Healthcare UK (No.5) Limited |
C17-aryl substituted betulinic acid analogs
|
MA40886B1
(fr)
|
2015-02-09 |
2020-03-31 |
Hetero Research Foundation |
Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih
|
WO2016147099A2
(en)
|
2015-03-16 |
2016-09-22 |
Hetero Research Foundation |
C-3 novel triterpenone with c-28 amide derivatives as hiv inhibitors
|
PL227790B1
(pl)
|
2015-08-13 |
2018-01-31 |
Slaski Univ Medyczny W Katowicach |
Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie.
|
AR107512A1
(es)
|
2016-02-04 |
2018-05-09 |
VIIV HEALTHCARE UK Nº 5 LTD |
Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1
|
EP3606532A4
(de)
*
|
2017-04-06 |
2020-11-18 |
Derm-Biome Pharmaceuticals Inc. |
Zusammensetzungen und verfahren zur behandlung von infektionen und neuen kosmetischen zubereitungen
|
PL237998B1
(pl)
|
2018-05-28 |
2021-06-28 |
Narodowy Inst Lekow |
Fosfonowe pochodne kwasu 3-karboksyacylobetulinowego, sposób ich otrzymywania oraz ich zastosowanie
|
NZ769842A
(en)
|
2018-06-29 |
2023-01-27 |
Dfh Therapeutics |
Triterpene amine derivatives
|